These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17721434)

  • 1. Building better magic bullets--improving unconjugated monoclonal antibody therapy for cancer.
    Weiner LM
    Nat Rev Cancer; 2007 Sep; 7(9):701-6. PubMed ID: 17721434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 6. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies.
    Vollmers HP; Brändlein S
    Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
    Kershaw MH; Trapani JA; Smyth MJ
    Ther Immunol; 1995 Jun; 2(3):173-81. PubMed ID: 8885135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing engagement of the immune system by anti-tumor antibodies: an engineer's perspective.
    Desjarlais JR; Lazar GA; Zhukovsky EA; Chu SY
    Drug Discov Today; 2007 Nov; 12(21-22):898-910. PubMed ID: 17993407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies: better knowledge for a better use].
    Abès R; Dutertre CA; Teillaud JL
    Med Sci (Paris); 2009 Dec; 25(12):1011-9. PubMed ID: 20035672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody therapy for cancer.
    von Mehren M; Adams GP; Weiner LM
    Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-targeted drugs for the therapy of cancer.
    Pietersz GA; Krauer K
    J Drug Target; 1994; 2(3):183-215. PubMed ID: 7812691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based antiangiogenic cancer therapy.
    Sanz L; Alvarez-Vallina L
    Expert Opin Ther Targets; 2005 Dec; 9(6):1235-45. PubMed ID: 16300473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-specific antibody therapy for the treatment of cancer.
    Withoff S; Helfrich W; de Leij LF; Molema G
    Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in immunoconjugate cancer therapeutics.
    Payne G
    Cancer Cell; 2003 Mar; 3(3):207-12. PubMed ID: 12676579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of monoclonal antibodies in the diagnosis and therapy of cancer.
    Vaickus L; Foon KA
    Cancer Invest; 1991; 9(2):195-209. PubMed ID: 1863875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer antibodies.
    Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
    Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From "magic bullets" to specific cancer immunotherapy.
    Riether C; Schürch C; Ochsenbein AF
    Swiss Med Wkly; 2013; 143():w13734. PubMed ID: 23348718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.